BIO
Bio-Rad Laboratories
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: BIO
- PEG Ratio
As of Jun 22, 2026, BIO's PEG ratio of 0.45 reflects its valuation relative to its growth rate. This result reflects a P/E ratio of 48.22 measured against EPS growth of 107.7%.
BIO PEG ratio history
Bio-Rad Laboratories's nine years historical PEG ratio averages out to 0.1. Compared to historical data, BIO's 0.45 PEG ratio represents an increase of 350%. BIO hit its maximum PEG ratio of 0.47 during the Dec 2021 quarter over the last nine years. The Mar 2018 quarter marked the lowest reading at 0, indicating the most attractive growth-adjusted valuation.
Bio-Rad Laboratories PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.08 | 10.87 | 142.6% |
| 2024 | N/A | N/A | -199.5% |
| 2023 | N/A | N/A | 82.1% |
| 2022 | N/A | N/A | -185.4% |
| 2021 | 0.47 | 5.3 | 11.3% |
| 2020 | 0.04 | 4.55 | 117.4% |
| 2019 | 0.02 | 6.28 | 381.1% |
| 2018 | 0.1 | 18.96 | 197.3% |
| 2017 | 0.16 | 57.93 | 368.2% |
| 2016 | N/A | 207.14 | -76.5% |
| 2015 | 1.73 | 37.07 | 21.4% |
| 2014 | 2.97 | 39.14 | 13.2% |
| 2013 | N/A | 45.44 | -53.5% |
| 2012 | N/A | 17.96 | -8.5% |
| 2011 | N/A | 15.03 | -4.6% |
Bio-Rad Laboratories PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.44 | 47.81 | 107.7% |
| Dec 2025 | 0.08 | 10.87 | 142.6% |
| Sep 2025 | N/A | N/A | 12.3% |
| Jun 2025 | 0.16 | 20.35 | 125.1% |
| Mar 2025 | N/A | N/A | -612.9% |
| Dec 2024 | N/A | N/A | -199.5% |
| Sep 2024 | N/A | N/A | -361.1% |
| Jun 2024 | N/A | N/A | -213.1% |
| Mar 2024 | N/A | N/A | -62.2% |
| Dec 2023 | N/A | N/A | 82.1% |
| Sep 2023 | N/A | N/A | 97% |
| Jun 2023 | N/A | N/A | 76.6% |
| Mar 2023 | N/A | N/A | -141.9% |
| Dec 2022 | N/A | N/A | -185.4% |
| Sep 2022 | N/A | N/A | -190.2% |
BIO average PEG ratio chart
BIO's PEG ratio today is above the 5 and 10-year averages.
PEG comparison
With a PEG of 0.45, BIO ranks lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 0.55, Bio-Rad Laboratories's PEG is 18% lower.
BIO EPS growth
BIO Price vs fair value
BIO PEG vs peers
Among its peer stocks GE and TMO, BIO's PEG ratio comes in lower.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| BIO Bio-Rad Laboratories Inc | 0.45 | $7.52B |
| A Agilent Technologies Inc | 1.1 | $35.58B |
| GE General Electric Co | 1.63 | $365.15B |
| TMO Thermo Fisher Scientific Inc | 3.87 | $172.83B |
| BDX Becton Dickinson & Co | N/A | $38.9B |
| HBIO Harvard Bioscience Inc | N/A | $27.31M |
| JNJ Johnson & Johnson | N/A | $564.64B |
| DHR Danaher Corp | N/A | $126.99B |
Frequently asked questions
What is Bio-Rad Laboratories's PEG ratio?
Based on Jun 22, 2026 data, BIO shows a PEG ratio of 0.45.
What is the 5-year average PEG ratio for Bio-Rad Laboratories (BIO)?
Historical data over a 5-year period puts BIO's average PEG ratio at 0.21.
What is the highest PEG ratio for BIO?
In the last nine years, BIO's peak PEG ratio of 0.47 occurred in the Dec 2021 quarter.
How does the current PEG ratio for BIO compare to its historical average?
At present, BIO's PEG ratio runs 350% higher than its 9-year historical average.
Why is Bio-Rad Laboratories's PEG ratio so low?
Rapid earnings expansion combined with a modest valuation gives BIO a PEG ratio of 0.45.
How is BIO's PEG ratio calculated (Bio-Rad Laboratories PEG ratio formula)?
To calculate the PEG ratio, take the company's PE ratio and divide by its EPS growth rate (YoY TTM). As of Jun 22, 2026, Bio-Rad Laboratories carries a PE ratio of 48.22. Earnings grew at 107.7% over the TTM period ending Mar 2026. Applying the formula, this yields a PEG ratio of 0.45. PEG RATIO(0.45) = PE RATIO(48.22) / EPS GROWTH(107.7%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.